Vatelizumab
Vatelizumab (GBR500) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2) . Vatelizumab can be used for the research of multiple sclerosis[1].
Product Specifications
CAS Number
1238217-55-4
Product Name Alternative
GBR500
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vatelizumab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Vatelizumab]
Molecular Weight
(144.28 kDa)
References & Citations
[1]Johanna Breuer, et al. VLA-2 blockade in vivo by vatelizumab induces CD4+FoxP3+ regulatory T cells. Int Immunol. 2019 May 21;31 (6) :407-412.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470052-100 1x 100 µL
HCG-intact (HCGab/52), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TP308969 20 µg
Dymeclin (DYM) (NM_017653) Human Recombinant Protein
Sign In for Pricing
View Details 
